34 related articles for article (PubMed ID: 12806592)
1. AT2 receptor signaling and sympathetic regulation.
Gao L; Zucker IH
Curr Opin Pharmacol; 2011 Apr; 11(2):124-30. PubMed ID: 21159555
[TBL] [Abstract][Full Text] [Related]
2. Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.
Byku M; Macarthur H; Westfall TC
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2188-97. PubMed ID: 18835922
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
4. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
5. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
[TBL] [Abstract][Full Text] [Related]
8. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Nap A; Balt JC; Pfaffendorf M; Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor pharmacology and AT1-receptor blockers.
Chung O; Csikós T; Unger T
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S11-20; discussion S33-4. PubMed ID: 10076916
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes.
Timmermans PB; Chiu AT; Herblin WF; Wong PC; Smith RD
Am J Hypertens; 1992 Jun; 5(6 Pt 1):406-10. PubMed ID: 1524767
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data.
Brooks DP; Ohlstein EH; Ruffolo RR
Am Heart J; 1999 Sep; 138(3 Pt 2):246-51. PubMed ID: 10467220
[TBL] [Abstract][Full Text] [Related]
12. Differentiation in the angiotensin II receptor 1 blocker class on autonomic function.
Krum H
Curr Hypertens Rep; 2001 Sep; 3 Suppl 1():S17-23. PubMed ID: 11580884
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
